Anemoside B4 inhibits SARS-CoV-2 replication in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anemoside B4 inhibits SARS-CoV-2 replication in vitro and in vivo

Published:2023-12 Issue: Volume: Page:
ISSN:1674-6384
Container-title:Chinese Herbal Medicines
language:en
Short-container-title:Chinese Herbal Medicines

Author:

Xiao Mingyue,Luo Ronghua,Liang Qinghua,Jiang Honglv,Liu Yanli,Xu Guoqiang,Gao Hongwei,Zheng Yongtang,Xu Qiongming,Yang Shilin

Funder

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

Elsevier BV

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmacology

Reference15 articles.

1. Emerging coronaviruses: Genome structure, replication, and pathogenesis;Chen;Journal of Medical Virology,2020

2. Anemoside B4 protects against Klebsiella pneumoniae- and influenza virus FM1-induced pneumonia via the TLR4/Myd88 signaling pathway in mice;He;Chinese Medicine,2020

3. Anemoside B4 attenuates nephrotoxicity of cisplatin without reducing anti-tumor activity of cisplatin;He;Phytomedicine,2019

4. Jia, K. X., Li, Y. J., Liu T. G., Gu, X. H., & Li, X. J. Y. New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches. Chinese Herbal Medicines, 15(2),157-168.

5. Role of Chinese herbal medicinal ingredients in secretion of cytokines by PCV2-induced endothelial cells;Hu;Journal of Immunotoxicology,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP